396 related articles for article (PubMed ID: 3694532)
21. Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
Lynch JJ; Montgomery DG; Ventura A; Lucchesi BR
J Pharmacol Exp Ther; 1985 Jul; 234(1):72-80. PubMed ID: 3874285
[TBL] [Abstract][Full Text] [Related]
22. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
[TBL] [Abstract][Full Text] [Related]
23. Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.
Carmeliet E; Janssen PA; Marsboom R; Van Nueten JM; Xhonneux R
Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):104-30. PubMed ID: 637616
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F
Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340
[TBL] [Abstract][Full Text] [Related]
25. Electrophysiologic, haemodynamic and antiarrhythmic effects of the new class Ic agent 1-(2'-biphenyloxy)-2-tert.-butylamino-propanol-2-hydrochloride.
Chiladakis I; Hindricks G; Haverkamp W; Vogt J; Gülker H
Arzneimittelforschung; 1989 Sep; 39(9):1130-2. PubMed ID: 2590263
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic consequences of supraventricular tachycardias and their antiarrhythmic treatment.
Yusoff K; Tai YT; Campbell RW
Z Kardiol; 1988; 77 Suppl 5():137-42. PubMed ID: 3066035
[TBL] [Abstract][Full Text] [Related]
28. Antiarrhythmic effects of L-penbutolol and DL-propranolol. Comparison of the effects of these two drugs on conductivity and excitability in canine heart in vivo.
Yamada K; Toyama J; Nimi N; Sugenoya J; Ohno M; Sugiyama S
Jpn Heart J; 1979 Sep; 20(5):603-11. PubMed ID: 501926
[TBL] [Abstract][Full Text] [Related]
29. 1-[4-(2-ter-butyl-quinolyl)]-3-(4-piperidyl)propanol (PK 10139): a new potent and long-acting antiarrhythmic agent.
Mestre M; Bouetard G; Le Fur G; Renault C; Gueremy C; Uzan A
J Pharmacol Exp Ther; 1983 Apr; 225(1):158-63. PubMed ID: 6834268
[TBL] [Abstract][Full Text] [Related]
30. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
[TBL] [Abstract][Full Text] [Related]
31. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
[TBL] [Abstract][Full Text] [Related]
32. Effects of the novel class Ia and class III antiarrhythmic agent RS-87337 on myocardial conduction in the anaesthetised dog.
Allely MC; Alps BJ
Arch Int Pharmacodyn Ther; 1988; 295():138-46. PubMed ID: 3245729
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacology of 2'-[2-hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophenone (Propafenone, SA 79)-hydrochloride].
Hapke HJ; Prigge E
Arzneimittelforschung; 1976; 26(10):1849-57. PubMed ID: 1037204
[TBL] [Abstract][Full Text] [Related]
34. [Hemodynamics in ventricular arrhythmias and in their treatment].
Lüderitz B; Manz M
Z Kardiol; 1988; 77 Suppl 5():143-9. PubMed ID: 3066036
[TBL] [Abstract][Full Text] [Related]
35. Hypotensive and antiarrhythmic effects of a new alkaloid, the 13-hydroxylupanine-2-pyrrolcarbonic acid ester, from the Madagascan plant Cadia ellisiana.
Lindner E; Kaiser J; Schacht U
Arzneimittelforschung; 1976; 26(9):1651-7. PubMed ID: 11808
[TBL] [Abstract][Full Text] [Related]
36. Effects of dantrolene and verapamil on atrioventricular conduction and cardiovascular performance in dogs.
Lynch C; Durbin CG; Fisher NA; Veselis RA; Althaus JS
Anesth Analg; 1986 Mar; 65(3):252-8. PubMed ID: 3954091
[TBL] [Abstract][Full Text] [Related]
37. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the electrophysiologic, antiarrhythmic and haemodynamic profile of a new isoquinolinedione derivative.
Gülker H; Spyra W; Thale J; Krimphove F; Hübner A; Bender F
Arzneimittelforschung; 1987 Aug; 37(8):917-9. PubMed ID: 3675686
[TBL] [Abstract][Full Text] [Related]
39. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
[No Abstract] [Full Text] [Related]
40. Cardiovascular and antiarrhythmic effects of the azulene-1-carboxamidine derivative N1,N1-dimethyl-N2-(2-pyridylmethyl)-5-isopropyl-3, 8-dimethylazulene-1-carboxamidine.
Saitoh M; Sugiyama A; Hagihara A; Nakazawa T; Hashimoto K
Arzneimittelforschung; 1997 Jul; 47(7):810-5. PubMed ID: 9272236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
